November 12, 2021
Life Sciences
  • Health care conglomerate Johnson & Johnson announced it is planning to break up into two companies, separating its consumer health business into a new publicly traded company. “The new Johnson & Johnson and the New Consumer Health Company would each be able to more effectively allocate resources to deliver for patients and consumers, drive growth and unlock significant value,” said Joaquin Duato, who is expected to become the company’s CEO in January. (Press release here; Articles here, here, and here)